ONE VAXXINOVA

Newport Laboratories and Vaxxinova will be operating business as usual as dedicated partners in the effort to address animal health issues. In October 2021, Vaxxinova acquired Newport Laboratories to provide a more comprehensive offering of solutions to their customers.

Beginning in August, as we proceed with alignment of our two US businesses in Worthington and Willmar, we will begin re-branding our company name as Vaxxinova. Rest assured that Newport Labs is and will remain a critical brand of Vaxxinova for our custom-made vaccines and diagnostic services. Newport Labs and Vaxxinova remain committed to partnering with customers by providing better diagnostics that are supported by our global R&D network, the capability to create a diversified vaccine portfolio against many pathogens and providing superior customer service with MyVaxx.

For more information, please reach out to your Vaxxinova/Newport Labs representative or call us at 800-220-2522